Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05149404
Other study ID # LM2020289
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 1, 2020
Est. completion date December 30, 2021

Study information

Verified date June 2021
Source Peking University Third Hospital
Contact Yu Sun, Dr.
Phone 13501221484
Email sunyuor@vip.sina.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study intends to establish a multidisciplinary collaborative ERAS clinical pathway of cervical posterior surgery,and to verify its effectiveness, safety and value in health economics.


Description:

Enhanced recovery after surgery (ERAS) is a new model of deep cooperation between surgery,rehabilitation medicine, anesthesiology, nursing and other disciplines in recent years, which enables patients to start rehabilitation training as soon as possible after surgery and improves the comprehensive effect of surgery. Posterior cervical surgery is traumatic, and it is significant to enhance postoperative rehabilitation to improve the overall efficacy of patients. Currently, there are no clear guidelines supporting the clinical effectiveness of ERAS in reducing complications, reducing costs, and enhancing recovery after posterior cervical surgery. Therefore, this study aims to establish a multidisciplinary ERAS model for posterior cervical surgery in Peking University Third Hospital and verify its clinical effectiveness. This is a multi-center, multidisciplinary prospective cohort study,in which the orthopedics department was combined with the anesthesiology department, rehabilitation department, nutrition department, operating room and nursing team to establish the ERAS clinical pathways for posterior cervical spine surgery. Clinical pathways include surgical procedure optimization, rehabilitation procedure optimization, anesthesia and nursing procedure optimization. As it is optimized and promoted,the ERAS clinical pathways will improve the curative effect and prognosis of posterior cervical surgery, so that more patients with cervical spondylosis will benefit.


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date December 30, 2021
Est. primary completion date December 30, 2021
Accepts healthy volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: 1. Age 18-70, gender unlimited; 2. Diagnostic diagnosis of cervical spondylosis and consistent with the indications of posterior spinal canal extended laminoplasty; 3. Basis of serious diseases of centerlessness, brain, lung, kidney or other important organs, preoperative ASA score I-II; 4. Agree to participate in the study and sign the informed consent. Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Peking University Third Hospital Beijing Beijing

Sponsors (4)

Lead Sponsor Collaborator
Peking University Third Hospital Beijing Chao Yang Hospital, Beijing Tiantan Hospital, Peking University International Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary range of motion on X - ray range of motion the neck in extension and flexion on X - ray preoperation
Primary range of motion on X - ray range of motion the neck in extension and flexion on X - ray intraoperation
Primary range of motion on X - ray range of motion the neck in extension and flexion on X - ray 72 hours after surgery
Primary range of motion on X - ray range of motion the neck in extension and flexion on X - ray 3 months after surgery
Primary range of motion on X - ray range of motion the neck in extension and flexion on X - ray 6 months after surgery
Primary Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire(JOACMEQ) A questionare to evaluate the severity of cervical spondylosis myelopathy preoperation
Primary Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire(JOACMEQ) A questionare to evaluate the severity of cervical spondylosis myelopathy intraoperation
Primary Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire(JOACMEQ) A questionare to evaluate the severity of cervical spondylosis myelopathy 72 hours after surgery
Primary Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire(JOACMEQ) A questionare to evaluate the severity of cervical spondylosis myelopathy 3 months after surgery
Primary Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire(JOACMEQ) A questionare to evaluate the severity of cervical spondylosis myelopathy 6 months after surgery
Primary multi-cervical-unit system(MCU) To locate the cervical responsible section preoperation
Primary multi-cervical-unit system(MCU) To locate the cervical responsible section intraoperation
Primary multi-cervical-unit system(MCU) To locate the cervical responsible section 72 hours after surgery
Primary multi-cervical-unit system(MCU) To locate the cervical responsible section 3 months after surgery
Primary multi-cervical-unit system(MCU) To locate the cervical responsible section 6 months after surgery
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04952831 - Diffusion MRI in Cervical Spondylotic Myelopathy
Completed NCT00565734 - Surgical Treatment of Cervical Spondylotic Myelopathy Phase 4
Completed NCT00506558 - The CSM Trial: A Multicenter Study Comparing Ventral to Dorsal Surgery for Cervical Spondylotic Myelopathy Phase 3
Recruiting NCT00876603 - Anterior Vs Posterior Procedures for Cervical Spondylotic Myelopathy: Prospective Randomized Clinical Trial N/A
Recruiting NCT06377072 - Efficacy and Safety of Shenqi Sherong Pill in Participants With Cervical Spondylotic Myelopathy Phase 3
Enrolling by invitation NCT03513679 - Gait in Adult Patients With Cervical Spondylotic Myelopathy N/A
Completed NCT01257828 - Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect) Phase 3
Completed NCT04968054 - Comparison of IONM Between Remimazolam and Propofol N/A
Active, not recruiting NCT03296592 - Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)
Active, not recruiting NCT04955041 - Effectiveness of T2* MRI in Cervical Spondylotic Myelopathy
Completed NCT01061697 - Pregabalin and Radicular Pain Study (PARPS) Phase 4
Completed NCT03810781 - Postural Stability in Cervical Spinal Myelopathy
Recruiting NCT04936074 - Fusion or no Fusion After Decompression of the Spinal Cord in Patients With Degenerative Cervical Myelopathy N/A
Completed NCT00285337 - Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy N/A
Completed NCT02539394 - Effect of Topical Corticosteroids on Dysphagia in Anterior Cervical Discectomy and Fusion N/A